Quest PharmaTech Inc.
QPT.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 352.40K | 464.30K | 430.60K | 541.80K | 608.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 590.80K | 656.90K | 592.50K | 917.80K | 978.90K |
| Operating Income | -590.80K | -656.90K | -592.50K | -917.80K | -978.90K |
| Income Before Tax | -1.28M | -1.55M | -2.13M | -2.79M | -2.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.28 | -1.55 | -2.13 | -2.79 | -2.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.28M | -1.55M | -2.13M | -2.79M | -2.23M |
| EBIT | -590.80K | -656.90K | -592.50K | -917.80K | -978.90K |
| EBITDA | -588.60K | -655.20K | -591.40K | -915.30K | -976.70K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 676.52M | 676.52M | 676.52M | 676.52M | 676.52M |
| Average Diluted Shares Outstanding | 676.52M | 676.52M | 676.52M | 676.52M | 676.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |